Cercle

Name

Cercle

Legal name

Cercle.AI, Inc.

Website

https://cercle.ai

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Healthcare AI / Women's Health Data Intelligence

NAICS

Software Publishers (5132), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)

Keywords

• Healthcare AI platform
• Women's health data
• Biomedical graph
• Fertility AI software
• Clinical data analytics

Headquarters

HQ city

Frisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. AI Platform/SaaS Subscription: AI-powered platform providing data insights to healthcare providers and life science teams, likely delivered as a subscription or usage-based SaaS model.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Cercle sells an AI-enabled SaaS platform — the Cercle Biomedical Graph™ — that ingests, anonymizes, and harmonizes fragmented multimodal clinical data (genomic, EMR, imaging, notes, prescriptions) into a population-scale biomedical graph used by fertility clinics and life science teams for cohort discovery, embryo selection, predictive modeling, and clinical decision support. The platform is sold primarily to enterprise healthcare providers and life science organizations via a Book Demo / quote-based motion, with sub-products including the Fertility AI Tool, Predictor AI Tool, and a beta patient companion app called Luce.

Product overview

Cercle offers a unified AI platform called the Cercle Biomedical Graph™ for women's healthcare data intelligence. The platform architecture consists of three core components: the Ingestion Engine (which anonymizes and harmonizes multimodal clinical data), the Biomedical Graph (a multidimensional, population-scale representation connecting patients, events, and outcomes), and the Intelligence Layer (providing prediction, modeling, and decision support). The platform includes two specific AI tools — the Fertility AI Tool and Predictor AI Tool — as sub-products that help clinicians with embryo selection and treatment personalization in fertility care. The company also offers Luce, a patient-facing fertility companion app currently in beta. The platform transforms fragmented, unstructured healthcare data into real-time, high-quality insights used by healthcare providers, life science teams, and patients.

Differentiator

Problem solved

Functional benefit

Brands

• Cercle Biomedical Graph: AI-powered platform that transforms fragmented healthcare data into harmonized, anonymized insights by connecting patients, events, and outcomes across time, protocol, and clinical context.
• Cercle Intelligence Stack
• Luce
• Fertility AI Tool

Products and services

• Cercle Biomedical Graph Foundational AI platform that transforms fragmented healthcare data into a multidimensional, population-scale representation connecting patients, events, and outcomes across time, protocol, and clinical context for insight generation. Sold to enterprise healthcare providers and life science teams.
• Fertility AI Tool AI tool that connects data from all treatment stages of an IVF cycle and compares patient data with similar profiles and embryo characteristics from the Biomedical Graph to help clinicians make embryo selection decisions and develop personalized treatments. Targeted at fertility clinicians.
• Predictor AI Tool AI-powered predictive tool that uses anonymized patient data and population-scale insights from the Biomedical Graph to forecast fertility treatment outcomes. Targeted at fertility clinicians and care teams.
• Luce Beta-version fertility companion app for patients and clinicians that analyzes data from thousands of treatment cycles using the Biomedical Graph to deliver personalized insights based on similar fertility journeys. Targeted at women undergoing fertility treatment and their doctors.

Quantifiable outcome

• Analyzed more than 1 billion data points from anonymized patients globally
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• Ivy FertilitycoreStrategic or Co-development Partner · 16 June 2026Ivy Fertility chose Cercle as its data & AI/ML partner, implementing Cercle's platform across its nationwide clinic network of 14 fertility clinics. Partnership aims to improve patient outcomes, increase ART conversion, and streamline operations across clinical and administrative teams.
• MedITEXcoreChannel Partner/ Reseller/ Distributor · 16 June 2026Strategic partnership with MedITEX, the leading fertility EMR provider in Europe with 600+ partner clinics across 50+ countries. MedITEX will distribute Cercle's AI platform across its global network of fertility clinics.
• Eurofins GenomacoreStrategic or Co-development PartnerPartnership to bring Cercle Fertility AI Tool to hundreds of fertility and genetics clinics across Europe. Combining Eurofins' PGT and genomics data with Cercle's Biomedical Graph to improve IVF outcomes and personalize treatments.
• US FertilitycoreStrategic or Co-development PartnerEarly partner using the Cercle Biomedical Graph to organize unstructured, de-identified clinical data for analysis. Partnership optimizes research and internal quality assurance capabilities.
• Boston IVFsupportingStrategic or Co-development PartnerEarly customer using the Cercle Biomedical Graph since launch in November 2023 to drive efficiency and inform personalized treatments.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Tempus AI: AI-enabled precision medicine data platform serving providers and life sciences with multimodal clinical and molecular data. Highly comparable to Cercle's Biomedical Graph architecture and dual-provider/life-science GTM motion, though Tempus focuses on oncology rather than women's health.
• Flatiron Health: Real-world clinical and genomic data platform for oncology, acquired by Roche. Operates the same fundamental model as Cercle: aggregating fragmented EMR data into structured datasets for provider decision support and life science R&D.
• Komodo Health: Healthcare data analytics platform that maps patient journeys using de-identified data for life sciences and providers. Directly comparable to Cercle's patient-journey graph approach and life-science customer segment.
• Verana Health: Specialty-focused real-world data platform that integrates with specialty EHRs (including ophthalmology and neurology) to deliver curated datasets to life sciences. Closely comparable to Cercle's fertility-EMR partnership model with MedITEX.
• Aetion: Real-world evidence platform used by life sciences and regulators to evaluate treatment effectiveness. Comparable to Cercle's life-science use cases around cohort discovery, trial design, and R&D acceleration.
• Datavant: Healthcare data connectivity and de-identification infrastructure that links fragmented patient records across providers. Comparable to Cercle's Ingestion Engine layer that anonymizes and harmonizes multimodal clinical data.

Emerging players

• Atropos Health: AI-driven real-world evidence platform that generates clinician-grade observational studies from electronic health records. Comparable in its use of AI agents and NLP to surface clinical insights from fragmented data, though focused on provider decision support.
• Owkin: AI platform combining federated learning and multimodal patient data to support life sciences R&D and clinical research. Comparable AI-first architecture and life-science customer focus, though with different data-sharing and training approach.

Regional players

• Carrot Fertility: Fertility-focused benefits and care-navigation platform serving employers and patients. Comparable end market (fertility) but operates as a patient-facing benefits provider rather than a data/AI infrastructure layer like Cercle.
• Maven Clinic: Digital women's and family health platform serving employers and payers across fertility, maternity, and menopause. Comparable women's health vertical focus but delivers care rather than data infrastructure for clinics and life sciences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cercle